791 - Prematurity With Major Problems

A39.1 - Waterhouse-Friderichsen syndrome
A40.9 - Streptococcal sepsis, unspecified
A41.01 - Sepsis due to Methicillin susceptible Staphylococcus aureus
A41.02 - Sepsis due to Methicillin resistant Staphylococcus aureus
A41.1 - Sepsis due to other specified staphylococcus
A41.2 - Sepsis due to unspecified staphylococcus
A41.3 - Sepsis due to Hemophilus influenzae
A41.4 - Sepsis due to anaerobes
A41.50 - Gram-negative sepsis, unspecified
A41.51 - Sepsis due to Escherichia coli [E. coli]
A41.52 - Sepsis due to Pseudomonas
A41.53 - Sepsis due to Serratia
A41.54 - Sepsis due to Acinetobacter baumannii
A41.59 - Other Gram-negative sepsis
A41.81 - Sepsis due to Enterococcus
A41.89 - Other specified sepsis
A41.9 - Sepsis, unspecified organism
A42.7 - Actinomycotic sepsis
A48.0 - Gas gangrene
A48.51 - Infant botulism
B00.7 - Disseminated herpesviral disease
B00.89 - Other herpesviral infection
B01.0 - Varicella meningitis
B01.81 - Varicella keratitis
B01.89 - Other varicella complications
B01.9 - Varicella without complication
B02.7 - Disseminated zoster
B02.8 - Zoster with other complications
B05.1 - Measles complicated by meningitis
B05.4 - Measles with intestinal complications
B05.89 - Other measles complications
B06.81 - Rubella pneumonia
B06.89 - Other rubella complications
B08.20 - Exanthema subitum [sixth disease], unspecified
B08.21 - Exanthema subitum [sixth disease] due to human herpesvirus 6
B08.22 - Exanthema subitum [sixth disease] due to human herpesvirus 7
B26.82 - Mumps myocarditis
B26.83 - Mumps nephritis
B26.85 - Mumps arthritis
B26.89 - Other mumps complications
B38.7 - Disseminated coccidioidomycosis
B38.89 - Other forms of coccidioidomycosis
B40.0 - Acute pulmonary blastomycosis
B40.1 - Chronic pulmonary blastomycosis
B40.2 - Pulmonary blastomycosis, unspecified
B40.3 - Cutaneous blastomycosis
B40.7 - Disseminated blastomycosis
B40.81 - Blastomycotic meningoencephalitis
B40.89 - Other forms of blastomycosis
B40.9 - Blastomycosis, unspecified
B41.0 - Pulmonary paracoccidioidomycosis
B41.7 - Disseminated paracoccidioidomycosis
B41.8 - Other forms of paracoccidioidomycosis
B41.9 - Paracoccidioidomycosis, unspecified
B44.1 - Other pulmonary aspergillosis
B44.2 - Tonsillar aspergillosis
B44.7 - Disseminated aspergillosis
B44.89 - Other forms of aspergillosis
B44.9 - Aspergillosis, unspecified
B45.0 - Pulmonary cryptococcosis
B45.2 - Cutaneous cryptococcosis
B45.3 - Osseous cryptococcosis
B45.7 - Disseminated cryptococcosis
B45.8 - Other forms of cryptococcosis
B45.9 - Cryptococcosis, unspecified
B46.0 - Pulmonary mucormycosis
B46.1 - Rhinocerebral mucormycosis
B46.2 - Gastrointestinal mucormycosis
B46.3 - Cutaneous mucormycosis
B46.4 - Disseminated mucormycosis
B46.5 - Mucormycosis, unspecified
B46.8 - Other zygomycoses
B46.9 - Zygomycosis, unspecified
B47.0 - Eumycetoma
B48.2 - Allescheriasis
B48.4 - Penicillosis
B48.8 - Other specified mycoses
B58.00 - Toxoplasma oculopathy, unspecified
B58.82 - Toxoplasma myositis
B58.83 - Toxoplasma tubulo-interstitial nephropathy
B58.89 - Toxoplasmosis with other organ involvement
B97.4 - Respiratory syncytial virus as the cause of diseases classified elsewhere
D56.0 - Alpha thalassemia
D56.1 - Beta thalassemia
D56.2 - Delta-beta thalassemia
D56.5 - Hemoglobin E-beta thalassemia
D56.8 - Other thalassemias
D56.9 - Thalassemia, unspecified
D57.40 - Sickle-cell thalassemia without crisis
D57.411 - Sickle-cell thalassemia, unspecified, with acute chest syndrome
D57.412 - Sickle-cell thalassemia, unspecified, with splenic sequestration
D57.413 - Sickle-cell thalassemia, unspecified, with cerebral vascular involvement
D57.414 - Sickle-cell thalassemia, unspecified, with dactylitis
D57.418 - Sickle-cell thalassemia, unspecified, with crisis with other specified complication
D57.419 - Sickle-cell thalassemia, unspecified, with crisis
D57.42 - Sickle-cell thalassemia beta zero without crisis
D57.431 - Sickle-cell thalassemia beta zero with acute chest syndrome
D57.432 - Sickle-cell thalassemia beta zero with splenic sequestration
D57.433 - Sickle-cell thalassemia beta zero with cerebral vascular involvement
D57.434 - Sickle-cell thalassemia beta zero with dactylitis
D57.438 - Sickle-cell thalassemia beta zero with crisis with other specified complication
D57.439 - Sickle-cell thalassemia beta zero with crisis, unspecified
D57.44 - Sickle-cell thalassemia beta plus without crisis
D57.451 - Sickle-cell thalassemia beta plus with acute chest syndrome
D57.452 - Sickle-cell thalassemia beta plus with splenic sequestration
D57.453 - Sickle-cell thalassemia beta plus with cerebral vascular involvement
D57.454 - Sickle-cell thalassemia beta plus with dactylitis
D57.458 - Sickle-cell thalassemia beta plus with crisis with other specified complication
D57.459 - Sickle-cell thalassemia beta plus with crisis, unspecified
D59.2 - Drug-induced nonautoimmune hemolytic anemia
D59.30 - Hemolytic-uremic syndrome, unspecified
D59.31 - Infection-associated hemolytic-uremic syndrome
D59.32 - Hereditary hemolytic-uremic syndrome
D59.39 - Other hemolytic-uremic syndrome
D59.4 - Other nonautoimmune hemolytic anemias
D59.5 - Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]
D59.6 - Hemoglobinuria due to hemolysis from other external causes
D59.8 - Other acquired hemolytic anemias
D59.9 - Acquired hemolytic anemia, unspecified
D69.51 - Posttransfusion purpura
D69.59 - Other secondary thrombocytopenia
D75.821 - Non-immune heparin-induced thrombocytopenia
D75.822 - Immune-mediated heparin-induced thrombocytopenia
D75.828 - Other heparin-induced thrombocytopenia syndrome
D75.829 - Heparin-induced thrombocytopenia, unspecified
D75.84 - Other platelet-activating anti-PF4 disorders
D78.11 - Accidental puncture and laceration of the spleen during a procedure on the spleen
D78.12 - Accidental puncture and laceration of the spleen during other procedure
E32.1 - Abscess of thymus
E36.11 - Accidental puncture and laceration of an endocrine system organ or structure during an endocrine system procedure
E36.12 - Accidental puncture and laceration of an endocrine system organ or structure during other procedure
E84.11 - Meconium ileus in cystic fibrosis
F11.13 - Opioid abuse with withdrawal
F11.23 - Opioid dependence with withdrawal
F11.93 - Opioid use, unspecified with withdrawal
F13.130 - Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated
F13.131 - Sedative, hypnotic or anxiolytic abuse with withdrawal delirium
F13.132 - Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance
F13.139 - Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified
F13.230 - Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated
F13.231 - Sedative, hypnotic or anxiolytic dependence with withdrawal delirium
F13.232 - Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance
F13.239 - Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified
F13.930 - Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated
F13.931 - Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium
F13.932 - Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances
F13.939 - Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified
F14.13 - Cocaine abuse, unspecified with withdrawal
F14.23 - Cocaine dependence with withdrawal
F14.93 - Cocaine use, unspecified with withdrawal
F15.13 - Other stimulant abuse with withdrawal
F15.23 - Other stimulant dependence with withdrawal
F15.93 - Other stimulant use, unspecified with withdrawal
F17.203 - Nicotine dependence unspecified, with withdrawal
F17.213 - Nicotine dependence, cigarettes, with withdrawal
F17.223 - Nicotine dependence, chewing tobacco, with withdrawal
F17.293 - Nicotine dependence, other tobacco product, with withdrawal
F19.130 - Other psychoactive substance abuse with withdrawal, uncomplicated
F19.131 - Other psychoactive substance abuse with withdrawal delirium
F19.132 - Other psychoactive substance abuse with withdrawal with perceptual disturbance
F19.139 - Other psychoactive substance abuse with withdrawal, unspecified
F19.230 - Other psychoactive substance dependence with withdrawal, uncomplicated
F19.231 - Other psychoactive substance dependence with withdrawal delirium
F19.232 - Other psychoactive substance dependence with withdrawal with perceptual disturbance
F19.239 - Other psychoactive substance dependence with withdrawal, unspecified
F19.930 - Other psychoactive substance use, unspecified with withdrawal, uncomplicated
F19.931 - Other psychoactive substance use, unspecified with withdrawal delirium
F19.932 - Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance
F19.939 - Other psychoactive substance use, unspecified with withdrawal, unspecified
G96.11 - Dural tear
G97.41 - Accidental puncture or laceration of dura during a procedure
G97.48 - Accidental puncture and laceration of other nervous system organ or structure during a nervous system procedure
G97.49 - Accidental puncture and laceration of other nervous system organ or structure during other procedure
H59.211 - Accidental puncture and laceration of right eye and adnexa during an ophthalmic procedure
H59.212 - Accidental puncture and laceration of left eye and adnexa during an ophthalmic procedure
H59.213 - Accidental puncture and laceration of eye and adnexa during an ophthalmic procedure, bilateral
H59.219 - Accidental puncture and laceration of unspecified eye and adnexa during an ophthalmic procedure
H59.221 - Accidental puncture and laceration of right eye and adnexa during other procedure
H59.222 - Accidental puncture and laceration of left eye and adnexa during other procedure
H59.223 - Accidental puncture and laceration of eye and adnexa during other procedure, bilateral
H59.229 - Accidental puncture and laceration of unspecified eye and adnexa during other procedure
H95.31 - Accidental puncture and laceration of the ear and mastoid process during a procedure on the ear and mastoid process
H95.32 - Accidental puncture and laceration of the ear and mastoid process during other procedure
I97.51 - Accidental puncture and laceration of a circulatory system organ or structure during a circulatory system procedure
I97.52 - Accidental puncture and laceration of a circulatory system organ or structure during other procedure
J95.71 - Accidental puncture and laceration of a respiratory system organ or structure during a respiratory system procedure
J95.72 - Accidental puncture and laceration of a respiratory system organ or structure during other procedure
K68.11 - Postprocedural retroperitoneal abscess
K91.71 - Accidental puncture and laceration of a digestive system organ or structure during a digestive system procedure
K91.72 - Accidental puncture and laceration of a digestive system organ or structure during other procedure
L04.0 - Acute lymphadenitis of face, head and neck
L04.1 - Acute lymphadenitis of trunk
L04.2 - Acute lymphadenitis of upper limb
L04.3 - Acute lymphadenitis of lower limb
L04.8 - Acute lymphadenitis of other sites
L04.9 - Acute lymphadenitis, unspecified
L76.11 - Accidental puncture and laceration of skin and subcutaneous tissue during a dermatologic procedure
L76.12 - Accidental puncture and laceration of skin and subcutaneous tissue during other procedure
M96.820 - Accidental puncture and laceration of a musculoskeletal structure during a musculoskeletal system procedure
M96.821 - Accidental puncture and laceration of a musculoskeletal structure during other procedure
N98.0 - Infection associated with artificial insemination
N99.71 - Accidental puncture and laceration of a genitourinary system organ or structure during a genitourinary system procedure
N99.72 - Accidental puncture and laceration of a genitourinary system organ or structure during other procedure
P03.4 - Newborn affected by Cesarean delivery
P05.11 - Newborn small for gestational age, less than 500 grams
P05.12 - Newborn small for gestational age, 500-749 grams
P05.13 - Newborn small for gestational age, 750-999 grams
P05.14 - Newborn small for gestational age, 1000-1249 grams
P05.15 - Newborn small for gestational age, 1250-1499 grams
P05.16 - Newborn small for gestational age, 1500-1749 grams
P05.17 - Newborn small for gestational age, 1750-1999 grams
P05.2 - Newborn affected by fetal (intrauterine) malnutrition not light or small for gestational age
P07.10 - Other low birth weight newborn, unspecified weight
P07.14 - Other low birth weight newborn, 1000-1249 grams
P07.15 - Other low birth weight newborn, 1250-1499 grams
P07.16 - Other low birth weight newborn, 1500-1749 grams
P07.17 - Other low birth weight newborn, 1750-1999 grams
P07.18 - Other low birth weight newborn, 2000-2499 grams
P07.30 - Preterm newborn, unspecified weeks of gestation
P07.31 - Preterm newborn, gestational age 28 completed weeks
P07.32 - Preterm newborn, gestational age 29 completed weeks
P07.33 - Preterm newborn, gestational age 30 completed weeks
P07.34 - Preterm newborn, gestational age 31 completed weeks
P07.35 - Preterm newborn, gestational age 32 completed weeks
P07.36 - Preterm newborn, gestational age 33 completed weeks
P07.37 - Preterm newborn, gestational age 34 completed weeks
P07.38 - Preterm newborn, gestational age 35 completed weeks
P07.39 - Preterm newborn, gestational age 36 completed weeks
P10.0 - Subdural hemorrhage due to birth injury
P10.1 - Cerebral hemorrhage due to birth injury
P10.2 - Intraventricular hemorrhage due to birth injury
P10.3 - Subarachnoid hemorrhage due to birth injury
P10.4 - Tentorial tear due to birth injury
P10.8 - Other intracranial lacerations and hemorrhages due to birth injury
P10.9 - Unspecified intracranial laceration and hemorrhage due to birth injury
P11.0 - Cerebral edema due to birth injury
P11.2 - Unspecified brain damage due to birth injury
P11.4 - Birth injury to other cranial nerves
P11.5 - Birth injury to spine and spinal cord
P11.9 - Birth injury to central nervous system, unspecified
P12.2 - Epicranial subaponeurotic hemorrhage due to birth injury
P14.2 - Phrenic nerve paralysis due to birth injury
P14.8 - Birth injuries to other parts of peripheral nervous system
P14.9 - Birth injury to peripheral nervous system, unspecified
P23.0 - Congenital pneumonia due to viral agent
P23.1 - Congenital pneumonia due to Chlamydia
P23.2 - Congenital pneumonia due to staphylococcus
P23.3 - Congenital pneumonia due to streptococcus, group B
P23.4 - Congenital pneumonia due to Escherichia coli
P23.5 - Congenital pneumonia due to Pseudomonas
P23.6 - Congenital pneumonia due to other bacterial agents
P23.8 - Congenital pneumonia due to other organisms
P23.9 - Congenital pneumonia, unspecified
P24.00 - Meconium aspiration without respiratory symptoms
P24.01 - Meconium aspiration with respiratory symptoms
P24.10 - Neonatal aspiration of (clear) amniotic fluid and mucus without respiratory symptoms
P24.11 - Neonatal aspiration of (clear) amniotic fluid and mucus with respiratory symptoms
P24.20 - Neonatal aspiration of blood without respiratory symptoms
P24.21 - Neonatal aspiration of blood with respiratory symptoms
P24.30 - Neonatal aspiration of milk and regurgitated food without respiratory symptoms
P24.31 - Neonatal aspiration of milk and regurgitated food with respiratory symptoms
P24.80 - Other neonatal aspiration without respiratory symptoms
P24.81 - Other neonatal aspiration with respiratory symptoms
P24.9 - Neonatal aspiration, unspecified
P25.0 - Interstitial emphysema originating in the perinatal period
P25.1 - Pneumothorax originating in the perinatal period
P25.2 - Pneumomediastinum originating in the perinatal period
P25.3 - Pneumopericardium originating in the perinatal period
P25.8 - Other conditions related to interstitial emphysema originating in the perinatal period
P26.0 - Tracheobronchial hemorrhage originating in the perinatal period
P26.1 - Massive pulmonary hemorrhage originating in the perinatal period
P26.8 - Other pulmonary hemorrhages originating in the perinatal period
P26.9 - Unspecified pulmonary hemorrhage originating in the perinatal period
P28.0 - Primary atelectasis of newborn
P28.5 - Respiratory failure of newborn
P29.30 - Pulmonary hypertension of newborn
P29.38 - Other persistent fetal circulation
P29.81 - Cardiac arrest of newborn
P35.0 - Congenital rubella syndrome
P35.1 - Congenital cytomegalovirus infection
P35.2 - Congenital herpesviral [herpes simplex] infection
P35.3 - Congenital viral hepatitis
P35.4 - Congenital Zika virus disease
P35.8 - Other congenital viral diseases
P35.9 - Congenital viral disease, unspecified
P36.0 - Sepsis of newborn due to streptococcus, group B
P36.10 - Sepsis of newborn due to unspecified streptococci
P36.19 - Sepsis of newborn due to other streptococci
P36.2 - Sepsis of newborn due to Staphylococcus aureus
P36.30 - Sepsis of newborn due to unspecified staphylococci
P36.39 - Sepsis of newborn due to other staphylococci
P36.4 - Sepsis of newborn due to Escherichia coli
P36.5 - Sepsis of newborn due to anaerobes
P36.8 - Other bacterial sepsis of newborn
P36.9 - Bacterial sepsis of newborn, unspecified
P37.0 - Congenital tuberculosis
P37.1 - Congenital toxoplasmosis
P37.2 - Neonatal (disseminated) listeriosis
P37.3 - Congenital falciparum malaria
P37.4 - Other congenital malaria
P37.8 - Other specified congenital infectious and parasitic diseases
P37.9 - Congenital infectious or parasitic disease, unspecified
P38.1 - Omphalitis with mild hemorrhage
P38.9 - Omphalitis without hemorrhage
P39.0 - Neonatal infective mastitis
P39.2 - Intra-amniotic infection affecting newborn, not elsewhere classified
P39.3 - Neonatal urinary tract infection
P39.4 - Neonatal skin infection
P39.8 - Other specified infections specific to the perinatal period
P39.9 - Infection specific to the perinatal period, unspecified
P50.0 - Newborn affected by intrauterine (fetal) blood loss from vasa previa
P50.1 - Newborn affected by intrauterine (fetal) blood loss from ruptured cord
P50.2 - Newborn affected by intrauterine (fetal) blood loss from placenta
P50.3 - Newborn affected by hemorrhage into co-twin
P50.4 - Newborn affected by hemorrhage into maternal circulation
P50.5 - Newborn affected by intrauterine (fetal) blood loss from cut end of co-twin's cord
P50.8 - Newborn affected by other intrauterine (fetal) blood loss
P50.9 - Newborn affected by intrauterine (fetal) blood loss, unspecified
P52.0 - Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
P52.1 - Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn
P52.21 - Intraventricular (nontraumatic) hemorrhage, grade 3, of newborn
P52.22 - Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
P52.3 - Unspecified intraventricular (nontraumatic) hemorrhage of newborn
P52.4 - Intracerebral (nontraumatic) hemorrhage of newborn
P52.5 - Subarachnoid (nontraumatic) hemorrhage of newborn
P52.6 - Cerebellar (nontraumatic) and posterior fossa hemorrhage of newborn
P52.8 - Other intracranial (nontraumatic) hemorrhages of newborn
P52.9 - Intracranial (nontraumatic) hemorrhage of newborn, unspecified
P54.1 - Neonatal melena
P54.2 - Neonatal rectal hemorrhage
P54.3 - Other neonatal gastrointestinal hemorrhage
P54.4 - Neonatal adrenal hemorrhage
P55.8 - Other hemolytic diseases of newborn
P55.9 - Hemolytic disease of newborn, unspecified
P56.0 - Hydrops fetalis due to isoimmunization
P56.90 - Hydrops fetalis due to unspecified hemolytic disease
P56.99 - Hydrops fetalis due to other hemolytic disease
P57.0 - Kernicterus due to isoimmunization
P57.8 - Other specified kernicterus
P57.9 - Kernicterus, unspecified
P59.1 - Inspissated bile syndrome
P59.20 - Neonatal jaundice from unspecified hepatocellular damage
P59.29 - Neonatal jaundice from other hepatocellular damage
P61.0 - Transient neonatal thrombocytopenia
P61.2 - Anemia of prematurity
P61.6 - Other transient neonatal disorders of coagulation
P70.2 - Neonatal diabetes mellitus
P70.3 - Iatrogenic neonatal hypoglycemia
P70.4 - Other neonatal hypoglycemia
P71.0 - Cow's milk hypocalcemia in newborn
P71.1 - Other neonatal hypocalcemia
P71.2 - Neonatal hypomagnesemia
P71.3 - Neonatal tetany without calcium or magnesium deficiency
P71.4 - Transitory neonatal hypoparathyroidism
P71.8 - Other transitory neonatal disorders of calcium and magnesium metabolism
P71.9 - Transitory neonatal disorder of calcium and magnesium metabolism, unspecified
P72.1 - Transitory neonatal hyperthyroidism
P74.0 - Late metabolic acidosis of newborn
P74.1 - Dehydration of newborn
P74.21 - Hypernatremia of newborn
P74.22 - Hyponatremia of newborn
P74.31 - Hyperkalemia of newborn
P74.32 - Hypokalemia of newborn
P74.421 - Hyperchloremia of newborn
P74.422 - Hypochloremia of newborn
P74.49 - Other transitory electrolyte disturbance of newborn
P76.0 - Meconium plug syndrome
P76.2 - Intestinal obstruction due to inspissated milk
P77.1 - Stage 1 necrotizing enterocolitis in newborn
P77.2 - Stage 2 necrotizing enterocolitis in newborn
P77.3 - Stage 3 necrotizing enterocolitis in newborn
P77.9 - Necrotizing enterocolitis in newborn, unspecified
P78.0 - Perinatal intestinal perforation
P83.2 - Hydrops fetalis not due to hemolytic disease
P91.0 - Neonatal cerebral ischemia
P91.1 - Acquired periventricular cysts of newborn
P91.3 - Neonatal cerebral irritability
P91.4 - Neonatal cerebral depression
P91.5 - Neonatal coma
P91.62 - Moderate hypoxic ischemic encephalopathy [HIE]
P91.63 - Severe hypoxic ischemic encephalopathy [HIE]
P91.811 - Neonatal encephalopathy in diseases classified elsewhere
P91.819 - Neonatal encephalopathy, unspecified
P91.821 - Neonatal cerebral infarction, right side of brain
P91.822 - Neonatal cerebral infarction, left side of brain
P91.823 - Neonatal cerebral infarction, bilateral
P91.829 - Neonatal cerebral infarction, unspecified side
P91.88 - Other specified disturbances of cerebral status of newborn
P91.9 - Disturbance of cerebral status of newborn, unspecified
P92.01 - Bilious vomiting of newborn
P93.0 - Grey baby syndrome
P93.8 - Other reactions and intoxications due to drugs administered to newborn
P94.0 - Transient neonatal myasthenia gravis
P96.1 - Neonatal withdrawal symptoms from maternal use of drugs of addiction
P96.2 - Withdrawal symptoms from therapeutic use of drugs in newborn
R78.81 - Bacteremia
S15.001A - Unspecified injury of right carotid artery, initial encounter
S15.002A - Unspecified injury of left carotid artery, initial encounter
S15.009A - Unspecified injury of unspecified carotid artery, initial encounter
S15.011A - Minor laceration of right carotid artery, initial encounter
S15.012A - Minor laceration of left carotid artery, initial encounter
S15.019A - Minor laceration of unspecified carotid artery, initial encounter
S15.021A - Major laceration of right carotid artery, initial encounter
S15.022A - Major laceration of left carotid artery, initial encounter
S15.029A - Major laceration of unspecified carotid artery, initial encounter
S15.091A - Other specified injury of right carotid artery, initial encounter
S15.092A - Other specified injury of left carotid artery, initial encounter
S15.099A - Other specified injury of unspecified carotid artery, initial encounter
S15.201A - Unspecified injury of right external jugular vein, initial encounter
S15.202A - Unspecified injury of left external jugular vein, initial encounter
S15.209A - Unspecified injury of unspecified external jugular vein, initial encounter
S15.211A - Minor laceration of right external jugular vein, initial encounter
S15.212A - Minor laceration of left external jugular vein, initial encounter
S15.219A - Minor laceration of unspecified external jugular vein, initial encounter
S15.221A - Major laceration of right external jugular vein, initial encounter
S15.222A - Major laceration of left external jugular vein, initial encounter
S15.229A - Major laceration of unspecified external jugular vein, initial encounter
S15.291A - Other specified injury of right external jugular vein, initial encounter
S15.292A - Other specified injury of left external jugular vein, initial encounter
S15.299A - Other specified injury of unspecified external jugular vein, initial encounter
S15.301A - Unspecified injury of right internal jugular vein, initial encounter
S15.302A - Unspecified injury of left internal jugular vein, initial encounter
S15.309A - Unspecified injury of unspecified internal jugular vein, initial encounter
S15.311A - Minor laceration of right internal jugular vein, initial encounter
S15.312A - Minor laceration of left internal jugular vein, initial encounter
S15.319A - Minor laceration of unspecified internal jugular vein, initial encounter
S15.321A - Major laceration of right internal jugular vein, initial encounter
S15.322A - Major laceration of left internal jugular vein, initial encounter
S15.329A - Major laceration of unspecified internal jugular vein, initial encounter
S15.391A - Other specified injury of right internal jugular vein, initial encounter
S15.392A - Other specified injury of left internal jugular vein, initial encounter
S15.399A - Other specified injury of unspecified internal jugular vein, initial encounter
S25.00XA - Unspecified injury of thoracic aorta, initial encounter
S25.01XA - Minor laceration of thoracic aorta, initial encounter
S25.02XA - Major laceration of thoracic aorta, initial encounter
S25.09XA - Other specified injury of thoracic aorta, initial encounter
S25.101A - Unspecified injury of right innominate or subclavian artery, initial encounter
S25.102A - Unspecified injury of left innominate or subclavian artery, initial encounter
S25.109A - Unspecified injury of unspecified innominate or subclavian artery, initial encounter
S25.111A - Minor laceration of right innominate or subclavian artery, initial encounter
S25.112A - Minor laceration of left innominate or subclavian artery, initial encounter
S25.119A - Minor laceration of unspecified innominate or subclavian artery, initial encounter
S25.121A - Major laceration of right innominate or subclavian artery, initial encounter
S25.122A - Major laceration of left innominate or subclavian artery, initial encounter
S25.129A - Major laceration of unspecified innominate or subclavian artery, initial encounter
S25.191A - Other specified injury of right innominate or subclavian artery, initial encounter
S25.192A - Other specified injury of left innominate or subclavian artery, initial encounter
S25.199A - Other specified injury of unspecified innominate or subclavian artery, initial encounter
S25.20XA - Unspecified injury of superior vena cava, initial encounter
S25.21XA - Minor laceration of superior vena cava, initial encounter
S25.22XA - Major laceration of superior vena cava, initial encounter
S25.29XA - Other specified injury of superior vena cava, initial encounter
S25.301A - Unspecified injury of right innominate or subclavian vein, initial encounter
S25.302A - Unspecified injury of left innominate or subclavian vein, initial encounter
S25.309A - Unspecified injury of unspecified innominate or subclavian vein, initial encounter
S25.311A - Minor laceration of right innominate or subclavian vein, initial encounter
S25.312A - Minor laceration of left innominate or subclavian vein, initial encounter
S25.319A - Minor laceration of unspecified innominate or subclavian vein, initial encounter
S25.321A - Major laceration of right innominate or subclavian vein, initial encounter
S25.322A - Major laceration of left innominate or subclavian vein, initial encounter
S25.329A - Major laceration of unspecified innominate or subclavian vein, initial encounter
S25.391A - Other specified injury of right innominate or subclavian vein, initial encounter
S25.392A - Other specified injury of left innominate or subclavian vein, initial encounter
S25.399A - Other specified injury of unspecified innominate or subclavian vein, initial encounter
S25.401A - Unspecified injury of right pulmonary blood vessels, initial encounter
S25.402A - Unspecified injury of left pulmonary blood vessels, initial encounter
S25.409A - Unspecified injury of unspecified pulmonary blood vessels, initial encounter
S25.411A - Minor laceration of right pulmonary blood vessels, initial encounter
S25.412A - Minor laceration of left pulmonary blood vessels, initial encounter
S25.419A - Minor laceration of unspecified pulmonary blood vessels, initial encounter
S25.421A - Major laceration of right pulmonary blood vessels, initial encounter
S25.422A - Major laceration of left pulmonary blood vessels, initial encounter
S25.429A - Major laceration of unspecified pulmonary blood vessels, initial encounter
S25.491A - Other specified injury of right pulmonary blood vessels, initial encounter
S25.492A - Other specified injury of left pulmonary blood vessels, initial encounter
S25.499A - Other specified injury of unspecified pulmonary blood vessels, initial encounter
S35.00XA - Unspecified injury of abdominal aorta, initial encounter
S35.01XA - Minor laceration of abdominal aorta, initial encounter
S35.02XA - Major laceration of abdominal aorta, initial encounter
S35.09XA - Other injury of abdominal aorta, initial encounter
S35.10XA - Unspecified injury of inferior vena cava, initial encounter
S35.11XA - Minor laceration of inferior vena cava, initial encounter
S35.12XA - Major laceration of inferior vena cava, initial encounter
S35.19XA - Other injury of inferior vena cava, initial encounter
S36.00XA - Unspecified injury of spleen, initial encounter
S36.020A - Minor contusion of spleen, initial encounter
S36.021A - Major contusion of spleen, initial encounter
S36.029A - Unspecified contusion of spleen, initial encounter
S36.030A - Superficial (capsular) laceration of spleen, initial encounter
S36.031A - Moderate laceration of spleen, initial encounter
S36.032A - Major laceration of spleen, initial encounter
S36.039A - Unspecified laceration of spleen, initial encounter
S36.09XA - Other injury of spleen, initial encounter
T36.0X5A - Adverse effect of penicillins, initial encounter
T36.1X5A - Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
T36.2X5A - Adverse effect of chloramphenicol group, initial encounter
T36.3X5A - Adverse effect of macrolides, initial encounter
T36.4X5A - Adverse effect of tetracyclines, initial encounter
T36.5X5A - Adverse effect of aminoglycosides, initial encounter
T36.6X5A - Adverse effect of rifampicins, initial encounter
T36.7X5A - Adverse effect of antifungal antibiotics, systemically used, initial encounter
T36.8X5A - Adverse effect of other systemic antibiotics, initial encounter
T36.95XA - Adverse effect of unspecified systemic antibiotic, initial encounter
T37.0X5A - Adverse effect of sulfonamides, initial encounter
T37.1X5A - Adverse effect of antimycobacterial drugs, initial encounter
T37.2X5A - Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
T37.3X5A - Adverse effect of other antiprotozoal drugs, initial encounter
T37.4X5A - Adverse effect of anthelminthics, initial encounter
T37.5X5A - Adverse effect of antiviral drugs, initial encounter
T37.8X5A - Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
T37.95XA - Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
T38.0X5A - Adverse effect of glucocorticoids and synthetic analogues, initial encounter
T38.1X5A - Adverse effect of thyroid hormones and substitutes, initial encounter
T38.2X5A - Adverse effect of antithyroid drugs, initial encounter
T38.3X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
T38.4X5A - Adverse effect of oral contraceptives, initial encounter
T38.5X5A - Adverse effect of other estrogens and progestogens, initial encounter
T38.6X5A - Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
T38.7X5A - Adverse effect of androgens and anabolic congeners, initial encounter
T38.805A - Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
T38.815A - Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
T38.895A - Adverse effect of other hormones and synthetic substitutes, initial encounter
T38.905A - Adverse effect of unspecified hormone antagonists, initial encounter
T38.995A - Adverse effect of other hormone antagonists, initial encounter
T39.015A - Adverse effect of aspirin, initial encounter
T39.095A - Adverse effect of salicylates, initial encounter
T39.1X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter
T39.2X5A - Adverse effect of pyrazolone derivatives, initial encounter
T39.315A - Adverse effect of propionic acid derivatives, initial encounter
T39.395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39.4X5A - Adverse effect of antirheumatics, not elsewhere classified, initial encounter
T39.8X5A - Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
T39.95XA - Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
T40.0X5A - Adverse effect of opium, initial encounter
T40.2X5A - Adverse effect of other opioids, initial encounter
T40.3X5A - Adverse effect of methadone, initial encounter
T40.415A - Adverse effect of fentanyl or fentanyl analogs, initial encounter
T40.425A - Adverse effect of tramadol, initial encounter
T40.495A - Adverse effect of other synthetic narcotics, initial encounter
T40.5X5A - Adverse effect of cocaine, initial encounter
T40.605A - Adverse effect of unspecified narcotics, initial encounter
T40.695A - Adverse effect of other narcotics, initial encounter
T40.715A - Adverse effect of cannabis, initial encounter
T40.725A - Adverse effect of synthetic cannabinoids, initial encounter
T40.905A - Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
T40.995A - Adverse effect of other psychodysleptics [hallucinogens], initial encounter
T41.0X5A - Adverse effect of inhaled anesthetics, initial encounter
T41.1X5A - Adverse effect of intravenous anesthetics, initial encounter
T41.205A - Adverse effect of unspecified general anesthetics, initial encounter
T41.295A - Adverse effect of other general anesthetics, initial encounter
T41.3X5A - Adverse effect of local anesthetics, initial encounter
T41.45XA - Adverse effect of unspecified anesthetic, initial encounter
T41.5X5A - Adverse effect of therapeutic gases, initial encounter
T42.0X5A - Adverse effect of hydantoin derivatives, initial encounter
T42.1X5A - Adverse effect of iminostilbenes, initial encounter
T42.2X5A - Adverse effect of succinimides and oxazolidinediones, initial encounter
T42.3X5A - Adverse effect of barbiturates, initial encounter
T42.4X5A - Adverse effect of benzodiazepines, initial encounter
T42.5X5A - Adverse effect of mixed antiepileptics, initial encounter
T42.6X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
T42.75XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
T42.8X5A - Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
T43.015A - Adverse effect of tricyclic antidepressants, initial encounter
T43.025A - Adverse effect of tetracyclic antidepressants, initial encounter
T43.1X5A - Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
T43.205A - Adverse effect of unspecified antidepressants, initial encounter
T43.215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
T43.225A - Adverse effect of selective serotonin reuptake inhibitors, initial encounter
T43.295A - Adverse effect of other antidepressants, initial encounter
T43.3X5A - Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
T43.4X5A - Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
T43.505A - Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
T43.595A - Adverse effect of other antipsychotics and neuroleptics, initial encounter
T43.605A - Adverse effect of unspecified psychostimulants, initial encounter
T43.615A - Adverse effect of caffeine, initial encounter
T43.625A - Adverse effect of amphetamines, initial encounter
T43.635A - Adverse effect of methylphenidate, initial encounter
T43.655A - Adverse effect of methamphetamines, initial encounter
T43.695A - Adverse effect of other psychostimulants, initial encounter
T43.8X5A - Adverse effect of other psychotropic drugs, initial encounter
T43.95XA - Adverse effect of unspecified psychotropic drug, initial encounter
T44.0X5A - Adverse effect of anticholinesterase agents, initial encounter
T44.1X5A - Adverse effect of other parasympathomimetics [cholinergics], initial encounter
T44.2X5A - Adverse effect of ganglionic blocking drugs, initial encounter
T44.3X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T44.4X5A - Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
T44.5X5A - Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
T44.6X5A - Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
T44.7X5A - Adverse effect of beta-adrenoreceptor antagonists, initial encounter
T44.8X5A - Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44.905A - Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
T44.995A - Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
T45.0X5A - Adverse effect of antiallergic and antiemetic drugs, initial encounter
T45.1X5A - Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.2X5A - Adverse effect of vitamins, initial encounter
T45.3X5A - Adverse effect of enzymes, initial encounter
T45.4X5A - Adverse effect of iron and its compounds, initial encounter
T45.515A - Adverse effect of anticoagulants, initial encounter
T45.525A - Adverse effect of antithrombotic drugs, initial encounter
T45.605A - Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.615A - Adverse effect of thrombolytic drugs, initial encounter
T45.625A - Adverse effect of hemostatic drug, initial encounter
T45.695A - Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.7X5A - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T45.8X5A - Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.95XA - Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
T46.0X5A - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.1X5A - Adverse effect of calcium-channel blockers, initial encounter
T46.2X5A - Adverse effect of other antidysrhythmic drugs, initial encounter
T46.3X5A - Adverse effect of coronary vasodilators, initial encounter
T46.4X5A - Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T46.5X5A - Adverse effect of other antihypertensive drugs, initial encounter
T46.6X5A - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T46.7X5A - Adverse effect of peripheral vasodilators, initial encounter
T46.8X5A - Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T46.905A - Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46.995A - Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T47.0X5A - Adverse effect of histamine H2-receptor blockers, initial encounter
T47.1X5A - Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T47.2X5A - Adverse effect of stimulant laxatives, initial encounter
T47.3X5A - Adverse effect of saline and osmotic laxatives, initial encounter
T47.4X5A - Adverse effect of other laxatives, initial encounter
T47.5X5A - Adverse effect of digestants, initial encounter
T47.6X5A - Adverse effect of antidiarrheal drugs, initial encounter
T47.7X5A - Adverse effect of emetics, initial encounter
T47.8X5A - Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
T47.95XA - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T48.0X5A - Adverse effect of oxytocic drugs, initial encounter
T48.1X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T48.205A - Adverse effect of unspecified drugs acting on muscles, initial encounter
T48.295A - Adverse effect of other drugs acting on muscles, initial encounter
T48.3X5A - Adverse effect of antitussives, initial encounter
T48.4X5A - Adverse effect of expectorants, initial encounter
T48.5X5A - Adverse effect of other anti-common-cold drugs, initial encounter
T48.6X5A - Adverse effect of antiasthmatics, initial encounter
T48.905A - Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
T48.995A - Adverse effect of other agents primarily acting on the respiratory system, initial encounter
T49.0X5A - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T49.1X5A - Adverse effect of antipruritics, initial encounter
T49.2X5A - Adverse effect of local astringents and local detergents, initial encounter
T49.3X5A - Adverse effect of emollients, demulcents and protectants, initial encounter
T49.4X5A - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
T49.5X5A - Adverse effect of ophthalmological drugs and preparations, initial encounter
T49.6X5A - Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
T49.7X5A - Adverse effect of dental drugs, topically applied, initial encounter
T49.8X5A - Adverse effect of other topical agents, initial encounter
T49.95XA - Adverse effect of unspecified topical agent, initial encounter
T50.0X5A - Adverse effect of mineralocorticoids and their antagonists, initial encounter
T50.1X5A - Adverse effect of loop [high-ceiling] diuretics, initial encounter
T50.2X5A - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.3X5A - Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
T50.4X5A - Adverse effect of drugs affecting uric acid metabolism, initial encounter
T50.5X5A - Adverse effect of appetite depressants, initial encounter
T50.6X5A - Adverse effect of antidotes and chelating agents, initial encounter
T50.7X5A - Adverse effect of analeptics and opioid receptor antagonists, initial encounter
T50.8X5A - Adverse effect of diagnostic agents, initial encounter
T50.905A - Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
T50.915A - Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
T50.995A - Adverse effect of other drugs, medicaments and biological substances, initial encounter
T50.A15A - Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50.A25A - Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
T50.A95A - Adverse effect of other bacterial vaccines, initial encounter
T50.B15A - Adverse effect of smallpox vaccines, initial encounter
T50.B95A - Adverse effect of other viral vaccines, initial encounter
T50.Z15A - Adverse effect of immunoglobulin, initial encounter
T50.Z95A - Adverse effect of other vaccines and biological substances, initial encounter
T78.41XA - Arthus phenomenon, initial encounter
T79.2XXA - Traumatic secondary and recurrent hemorrhage and seroma, initial encounter
T79.4XXA - Traumatic shock, initial encounter
T80.22XA - Acute infection following transfusion, infusion, or injection of blood and blood products, initial encounter
T80.29XA - Infection following other infusion, transfusion and therapeutic injection, initial encounter
T80.30XA - ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
T80.310A - ABO incompatibility with acute hemolytic transfusion reaction, initial encounter
T80.311A - ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter
T80.319A - ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
T80.39XA - Other ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter
T80.40XA - Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
T80.410A - Rh incompatibility with acute hemolytic transfusion reaction, initial encounter
T80.411A - Rh incompatibility with delayed hemolytic transfusion reaction, initial encounter
T80.419A - Rh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
T80.49XA - Other Rh incompatibility reaction due to transfusion of blood or blood products, initial encounter
T80.51XA - Anaphylactic reaction due to administration of blood and blood products, initial encounter
T80.52XA - Anaphylactic reaction due to vaccination, initial encounter
T80.59XA - Anaphylactic reaction due to other serum, initial encounter
T80.61XA - Other serum reaction due to administration of blood and blood products, initial encounter
T80.62XA - Other serum reaction due to vaccination, initial encounter
T80.69XA - Other serum reaction due to other serum, initial encounter
T80.82XA - Complication of immune effector cellular therapy, initial encounter
T80.89XA - Other complications following infusion, transfusion and therapeutic injection, initial encounter
T80.910A - Acute hemolytic transfusion reaction, unspecified incompatibility, initial encounter
T80.911A - Delayed hemolytic transfusion reaction, unspecified incompatibility, initial encounter
T80.919A - Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, initial encounter
T80.92XA - Unspecified transfusion reaction, initial encounter
T80.A0XA - Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
T80.A10A - Non-ABO incompatibility with acute hemolytic transfusion reaction, initial encounter
T80.A11A - Non-ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter
T80.A19A - Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
T80.A9XA - Other non-ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter
T81.10XA - Postprocedural shock unspecified, initial encounter
T81.11XA - Postprocedural cardiogenic shock, initial encounter
T81.12XA - Postprocedural septic shock, initial encounter
T81.19XA - Other postprocedural shock, initial encounter
T81.40XA - Infection following a procedure, unspecified, initial encounter
T81.41XA - Infection following a procedure, superficial incisional surgical site, initial encounter
T81.42XA - Infection following a procedure, deep incisional surgical site, initial encounter
T81.43XA - Infection following a procedure, organ and space surgical site, initial encounter
T81.44XA - Sepsis following a procedure, initial encounter
T81.49XA - Infection following a procedure, other surgical site, initial encounter
T81.500A - Unspecified complication of foreign body accidentally left in body following surgical operation, initial encounter
T81.501A - Unspecified complication of foreign body accidentally left in body following infusion or transfusion, initial encounter
T81.502A - Unspecified complication of foreign body accidentally left in body following kidney dialysis, initial encounter
T81.503A - Unspecified complication of foreign body accidentally left in body following injection or immunization, initial encounter
T81.504A - Unspecified complication of foreign body accidentally left in body following endoscopic examination, initial encounter
T81.505A - Unspecified complication of foreign body accidentally left in body following heart catheterization, initial encounter
T81.506A - Unspecified complication of foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter
T81.507A - Unspecified complication of foreign body accidentally left in body following removal of catheter or packing, initial encounter
T81.508A - Unspecified complication of foreign body accidentally left in body following other procedure, initial encounter
T81.509A - Unspecified complication of foreign body accidentally left in body following unspecified procedure, initial encounter
T81.510A - Adhesions due to foreign body accidentally left in body following surgical operation, initial encounter
T81.511A - Adhesions due to foreign body accidentally left in body following infusion or transfusion, initial encounter
T81.512A - Adhesions due to foreign body accidentally left in body following kidney dialysis, initial encounter
T81.513A - Adhesions due to foreign body accidentally left in body following injection or immunization, initial encounter
T81.514A - Adhesions due to foreign body accidentally left in body following endoscopic examination, initial encounter
T81.515A - Adhesions due to foreign body accidentally left in body following heart catheterization, initial encounter
T81.516A - Adhesions due to foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter
T81.517A - Adhesions due to foreign body accidentally left in body following removal of catheter or packing, initial encounter
T81.518A - Adhesions due to foreign body accidentally left in body following other procedure, initial encounter
T81.519A - Adhesions due to foreign body accidentally left in body following unspecified procedure, initial encounter
T81.520A - Obstruction due to foreign body accidentally left in body following surgical operation, initial encounter
T81.521A - Obstruction due to foreign body accidentally left in body following infusion or transfusion, initial encounter
T81.522A - Obstruction due to foreign body accidentally left in body following kidney dialysis, initial encounter
T81.523A - Obstruction due to foreign body accidentally left in body following injection or immunization, initial encounter
T81.524A - Obstruction due to foreign body accidentally left in body following endoscopic examination, initial encounter
T81.525A - Obstruction due to foreign body accidentally left in body following heart catheterization, initial encounter
T81.526A - Obstruction due to foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter
T81.527A - Obstruction due to foreign body accidentally left in body following removal of catheter or packing, initial encounter
T81.528A - Obstruction due to foreign body accidentally left in body following other procedure, initial encounter
T81.529A - Obstruction due to foreign body accidentally left in body following unspecified procedure, initial encounter
T81.530A - Perforation due to foreign body accidentally left in body following surgical operation, initial encounter
T81.531A - Perforation due to foreign body accidentally left in body following infusion or transfusion, initial encounter
T81.532A - Perforation due to foreign body accidentally left in body following kidney dialysis, initial encounter
T81.533A - Perforation due to foreign body accidentally left in body following injection or immunization, initial encounter
T81.534A - Perforation due to foreign body accidentally left in body following endoscopic examination, initial encounter
T81.535A - Perforation due to foreign body accidentally left in body following heart catheterization, initial encounter
T81.536A - Perforation due to foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter
T81.537A - Perforation due to foreign body accidentally left in body following removal of catheter or packing, initial encounter
T81.538A - Perforation due to foreign body accidentally left in body following other procedure, initial encounter
T81.539A - Perforation due to foreign body accidentally left in body following unspecified procedure, initial encounter
T81.590A - Other complications of foreign body accidentally left in body following surgical operation, initial encounter
T81.591A - Other complications of foreign body accidentally left in body following infusion or transfusion, initial encounter
T81.592A - Other complications of foreign body accidentally left in body following kidney dialysis, initial encounter
T81.593A - Other complications of foreign body accidentally left in body following injection or immunization, initial encounter
T81.594A - Other complications of foreign body accidentally left in body following endoscopic examination, initial encounter
T81.595A - Other complications of foreign body accidentally left in body following heart catheterization, initial encounter
T81.596A - Other complications of foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter
T81.597A - Other complications of foreign body accidentally left in body following removal of catheter or packing, initial encounter
T81.598A - Other complications of foreign body accidentally left in body following other procedure, initial encounter
T81.599A - Other complications of foreign body accidentally left in body following unspecified procedure, initial encounter
T81.60XA - Unspecified acute reaction to foreign substance accidentally left during a procedure, initial encounter
T81.61XA - Aseptic peritonitis due to foreign substance accidentally left during a procedure, initial encounter
T81.69XA - Other acute reaction to foreign substance accidentally left during a procedure, initial encounter
T81.83XA - Persistent postprocedural fistula, initial encounter
T81.9XXA - Unspecified complication of procedure, initial encounter
T88.0XXA - Infection following immunization, initial encounter
T88.2XXA - Shock due to anesthesia, initial encounter
T88.53XA - Unintended awareness under general anesthesia during procedure, initial encounter
T88.59XA - Other complications of anesthesia, initial encounter